L’hôpital Saint-Louis est un hôpital de l’Assistance publique - Hôpitaux de Paris situé dans le 10ᵉ arrondissement de Paris, au nord de la rue Bichat, 1, avenue Claude-Vellefaux.

During the past decade, Hôpital Saint Louis. Service de dermatologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Saint Louis. Service de dermatologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored, "LEO Pharma" with 2 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Saint Louis. Service de dermatologie" #1 collaborator was "Institut de Recherches Internationales Servier" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Société de Dermatologie Française" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Saint Louis. Service de dermatologie" are "Basal Cell Carcinoma" (2 trials), "Actinic Keratosis (AK)" (1 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Cutaneous T Lymphoma" (1 trials) and "Leg Ulcer" (1 trials). Many other conditions were trialed in "Hôpital Saint Louis. Service de dermatologie" in a lesser frequency.

Most popular intervention types in "Hôpital Saint Louis. Service de dermatologie" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Bendamustine" (1 trials), "Cobimetinib" (1 trials), "Imiquimod Cream, 5%" (1 trials) and "Ingenol Mebutate Gel, 0.015%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Saint Louis. Service de dermatologie" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Saint Louis. Service de dermatologie". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hôpital Saint Louis. Service de dermatologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Saint Louis. Service de dermatologie, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".